IL1A and melanoma: To date, previous studies have shown that EDPs and/or VGVAPG peptide increase the production and/or secretion inflammatory markers such as IL-1α, IL-1β, and IL-6 in ligamentum flavum cells, synovial cells, and melanoma cell lines [63–65].